퀴아젠 (QGEN) 주가

퀴아젠(QGEN)는 NYSE에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $42.95 (-0.65%), 시가총액 $6.80B, PER 16.83, 52주 범위 $32.63 ~ $55.66.

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and as

핵심 지표

• 현재가: $42.95 (-0.65%)
• 시가총액: $6.80B
• PER (주가수익비율): 16.83
• 52주 최저~최고: $32.63 ~ $55.66
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NYSE

퀴아젠의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.

퀴아젠 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.9375

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.04
• 순이익률: 0.19%
• 영업이익률: 0.24%
• 배당수익률: 0.00%

자주 묻는 질문